PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-07-30

Date Title Company
30-Jul-2019 Mezzion Pharma announces positive results from the Fontan Udenafil Exercise Longitudinal (FUEL) Trial, in adolescents with single ventricle heart disease who have undergone the Fontan procedure Mezzion Pharma Co. Ltd.
30-Jul-2019 Investigational Subcutaneous Formulation of Vedolizumab Meets Primary Endpoint in Achieving Clinical Remission at Week 52 in Patients with Moderately to Severely Active Crohn's Disease Takeda Pharmaceutical
30-Jul-2019 New study highlights key characteristics of successful cell & gene therapy leaders The RSA Group
30-Jul-2019 Major Shareholder Announcement Genmab
30-Jul-2019 Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering Genmab
30-Jul-2019 Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics Boehringer Ingelheim
30-Jul-2019 Smart Cells release 21st Stem Cell Sample to treat a child with Cerebral Palsy Smart Cells
30-Jul-2019 BREAKING: UK animal experiment statistics indicate reluctance to embrace modern tools to advance British labs into the 21st century Humane Society International
30-Jul-2019 Helping robots to build new antibiotics University of Manchester
30-Jul-2019 Genmab Prices its Initial Public Offering of American Depositary Shares (ADSs) in the United States Genmab
30-Jul-2019 Sernova's Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data Sernova
30-Jul-2019 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2019 Genmab
30-Jul-2019 The Medication Adherence Expertise Center at the University of Groningen in the Netherlands links up with Elucid on final development of an advanced smart pill bottle to monitor patient adherence The Medication Adherence Expertise Center
30-Jul-2019 Mesothelioma UK Grant awarded for study into clinical decision-making for asbestos-related cancer patients
30-Jul-2019 Genmab Genmab Announces Submission of Biologics License Application to U.S. FDA for Subcutaneous Formulation of Daratumumab
30-Jul-2019 REGENXBIO To Host Conference Call on August 7 to Discuss Second Quarter 2019 Financial Results and Recent Operational Highlights REGENXBIO Inc.
30-Jul-2019 Amgen Reports Second Quarter 2019 Financial Results Amgen
30-Jul-2019 Array BioPharma Inc., a Subsidiary of Pfizer Inc., Announces Effective Date of Make-Whole Fundamental Change and Fundamental Change Company Notice Relating to its 2.625% Convertible Senior Notes due 2024 Array BioPharma
30-Jul-2019 Baltimore-Based Remedi SeniorCare Expands Technology-Enabled Pharmacy Services in Houston Remedi SeniorCare
30-Jul-2019 Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics Boehringer Ingelheim